Tag: located project

DuPont Expanding in Newark, Delaware

DuPont Chooses Delaware for Expansion of Semiconductor Materials Production


WILMINGTON, Del. (August 22, 2022) – DuPont Semiconductor Technologies, a business unit of DuPont Electronics & Industrial, and a leading producer of specialty materials used in the production of semiconductors, has chosen Glasgow, Delaware, for a $50 million expansion in response to growing industry demand.

Following an extensive site search throughout Northern Delaware and Maryland, DuPont Electronics & Industrial decided to expand its Semiconductor Technologies manufacturing operations into a new 385,000-square-foot facility near its existing Newark, Delaware, location. The new semiconductor manufacturing facility is planned to become the primary work site for more than 70 existing workers and create about 10 new positions in Delaware.

“The DuPont Company has been part of Delaware’s DNA for 220 years. With this expansion of their semiconductor division, the company is showing their commitment to our state and workforce,” said Governor John Carney. “This site will bring with it a new 385,000-square-foot facility and 10 new jobs close to its existing Newark campus at a time when semiconductors are needed more than ever. Thank you to DuPont Electronics & Industrial for continuing to make Delaware a part of the DuPont story.”

DuPont and its innovative technologies have played a key role in Delaware’s economy for over 220 years. Today, DuPont is a premier multi-industrial leader with technology-based materials and solutions that help transform industries and everyday life.

DuPont Semiconductor Manufacturing Ready to Serve  Growing Demand

DuPont Semiconductor Technologies delivers enabling materials for semiconductor fabrication, packaging and assembly. In Delaware, the Semiconductor Technologies team manufactures key materials used in chemical mechanical planarization (CMP), an essential step in modern semiconductor fabrication processes.

Semiconductors are vital parts of the technologies people depend upon daily around the world. Demand for semiconductor chips continues to grow, driven by global trends such as surges in data storage, 5G and other wireless communications, and automotive electronics. Increased reliance on digital technologies for online collaboration and cloud computing also highlight how critical semiconductor chips are to the global economy.

Poised for a decade of growth, the semiconductor industry is projected to become a trillion-dollar industry by 2030. With its latest investment, DuPont will be well positioned to serve customers in this growing industry from its Delaware facilities.

Supporting DuPont Electronics & Industrial’s investment of $50 million in equipment and fit out costs for the new site are a Jobs Performance Grant of $65,550 and a Capital of Expenditure Grant of $1,578,000 from the Delaware Strategic Fund. Distribution of grants from the Delaware Strategic Fund is dependent on the company meeting commitments as outlined to Delaware’s Council on Development Finance, which reviewed and approved the company’s request for up to $1,643,550 in total grant funding.

“DuPont materials for chemical mechanical planarization are an essential part of the semiconductor supply chain, used by customers around the world in highly sensitive semiconductor chip fabrication,” said John Singer, Vice President, Integrated Operations, DuPont Electronics & Industrial. “As we expand to meet industry growth, we’re pleased to have identified a new facility near our existing CMP manufacturing operations in Delaware, where we can continue to have close collaboration with our experienced colleagues in operations, engineering, quality and other interconnected teams.”

###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About DuPont Electronics & Industrial

DuPont Electronics & Industrial is a global supplier of new technologies and performance materials serving the semiconductor, circuit board, display, digital and flexographic printing, healthcare, aerospace, industrial and transportation industries. From advanced technology centers worldwide, teams of talented research scientists and application experts work closely with customers, providing solutions, products and technical service to enable next-generation technologies.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Royale Group Expanding to 2nd Delaware Site

Royale Group Expanding to Second Delaware Location

Company adding Royale Pigments & Chemicals site in Seaford to AWSM Solutions Delaware site in Bear, doubling its Delaware presence in just two years.


(WILMINGTON, Del.) – Royale Pigments & Chemicals, part of The Royale Group collection of specialty chemical companies, has chosen Seaford, Delaware, as the site for a $2.35 million expansion that will double The Royale Group’s Delaware presence since it relocated from New Jersey two years ago.

Royale’s investment in Sussex County includes purchase of the former BASF Polymer Plant at 100 Industrial Park Boulevard that is now owned by Delmarva Central Railroad. DCR operates a transloading facility at the on-site rail spur located there, but the building itself is underutilized with no active operations at present.

“The chemical industry has long been part of Delaware’s economy. Over the next three years, The Royale Group plans to purchase an underutilized site in Seaford, bringing new jobs and economic growth to Sussex County,” said Governor John Carney. “This will be Royale’s second facility in the state, showing their commitment to growing their business here. This campus is only possible because of Delaware’s world-class innovative workforce. Thank you to The Royale Group, the town of Seaford, the Delaware Prosperity Partnership and everyone else who made this acquisition possible.”

In 2020, Delaware Prosperity Partnership began working with The Royale Group as it made its first investment in Delaware by acquiring IMS Chemblend and the IMS facility at 400 Carson Drive in Bear, changing the operation’s name to AWSM Solutions Delaware and relocating Royale’s corporate headquarters from New Jersey to the New Castle County property. The company’s $1 million investment included adding 17 new jobs, and AWSM already has surpassed its job-growth projections with 30 active employees.

While continuing to invest and grow its Northern Delaware operations, Royale’s expansion to a second Delaware location with on-site rail access will allow it to better serve a growing roster of customers and secure new contracts with leading companies throughout the region. Royale’s Southern Delaware investment includes creating 29 new jobs – including chemical operator, maintenance/warehouse and manager/supervisor positions – over the next three years. 

Royale officials presented an application to Delaware’s Council on Development Finance for a Jobs Performance Grant of $177,930 and a Capital Expenditure Grant of $70,500 from the Delaware Strategic Fund to support the company’s investment of more than $2.35 million. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Royale’s request for up to $248,430 in total grant funding.

 “We are very excited to welcome Royale Pigments & Chemicals to Seaford, Delaware,” said Seaford Mayor David Genshaw. “Our city has seen an incredible wave of revitalization with the help of Delaware Prosperity Partnership, and we are grateful for their support and for Royale Pigments & Chemicals for choosing Seaford.” 

The Royale Group was drawn to establish operations in Delaware by the state’s educated workforce, lower cost of living and business-friendly government. Royale has quickly become an important part of Delaware’s chemical manufacturing and distribution sector, and its decision to invest in a second Delaware facility demonstrates its continued commitment to growing here.

“Delaware has been a great place to do business! There are many valuable resources to help start or move a business to the state,” said Royale Group CEO John Logue. “These resources range from the Delaware Prosperity Partnership to a dedicated and assigned omnibus person from the Delaware Department of Natural Resources and Environmental Control, providing assistance with Delaware’s regulatory agency. We are excited with the expansion of our manufacturing operation in Delaware.”

###

 About Delaware Prosperity Partnership

Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support  employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

 About The Royale Group

The Royale Group, recipient of the 2019 National Association of Chemical Distributors’ prestigious Distributor of the Year award, is a collection of specialty chemical companies that manufactures, formulates and distributes chemicals. Specifically, Royale Pigments & Chemicals distributes specialty colorants into the paint, coatings and fire retardants markets. Shorechem distributes and manufactures specialty chemicals into the pharma, metals, aerospace and automotive markets. AWSM Industries distributes and manufactures specialty chemicals into the chip fabrication, automotive and gas markets. Most recently acquired in 2020, AWSM Solutions toll manufactures, blends, formulates, breaks bulk packages and provides labels for products in the following markets: organic agrochem, pharma, electronics, cleaners, aerospace, marine and construction.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

WuXi STA Breaks Ground on Delaware Site

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

16 AUGUST, 2022 | WuXi News

WuXi STA new pharmaceutical manufacturing facility in Delaware

MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing site in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA’s second facility in the United States, offering expanded capacity and greater flexibility to meet customers’ needs in the U.S. and worldwide.

The WuXi STA Middletown site is located in the Middletown Business Center at 1091 Industrial Drive, and the new state-of-the-art facility will create approximately 500 full-time jobs by 2026. Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labeling, storage, and distribution services for clinical trial materials and commercial drug products.

WuXi STA has 12 sites across the U.S., Europe, and Asia that offer a range of services and meet or exceed all regulatory standards. Together with three other drug product manufacturing sites in Couvet (Switzerland), Wuxi City (China), and Shanghai (China), this new facility will further enhance the company’s global drug production capacity and capabilities. 

World Leader in Pharmaceutical Manufacturing and Research

“The biopharmaceutical industry is part of Delaware’s DNA,” said Delaware Governor John Carney. “Over the next five years, WuXi STA plans to build a state-of-the-art pharmaceutical manufacturing site in one of Delaware’s fastest-growing communities, bringing with it good jobs and economic growth. This campus is only possible because of Delaware’s world-class, innovative workforce. Thank you to WuXi STA, Middletown Mayor Kenny Branner and everyone who made this project possible.”

“The First State continues to be a first-rate destination for businesses looking to innovate and grow,” said Senator Tom Carper. “This investment by WuXi STA helps position Delaware as a continued global leader in biopharmaceuticals, further cementing the manufacturing might of one of our fastest growing communities. Delaware’s workforce is ready to help build the future of our life-saving pharmaceuticals. This state-of-the-art campus will create good jobs and help fortify our supply chains here at home.”

“This biopharmaceutical manufacturing site is one most significant private sector investment ever in the Middletown region,” said Senator Chris Coons. “I am excited about WuXi STA’s decision to choose Middletown for one of their new manufacturing facilities. This isn’t just the largest private-sector investment in Middletown’s history – it’s a defining moment that will bring many more good-paying jobs to Delaware and will further cement the First State as a world leader in biopharmaceutical research and manufacturing. Thanks are due to everyone from Middletown to Dover to Washington who helped us get to this point, whether by making continued investments in NIIMBL, improving our education system from kindergarten to our universities, or ensuring that Delaware workers have the skills manufacturers like WuXi AppTec are looking for.”

“As the First State, Delaware has always had a spirit of innovation – constantly seeking new opportunities and ventures that will strengthen our economy and our state as a whole,” said Rep. Lisa Blunt Rochester. “Today’s groundbreaking of the WuXi STA pharmaceutical manufacturing plant represents another step in that spirit of innovation – bringing good-paying jobs to Middletown and strengthening communities throughout Delaware. The state-of-the-art facility will bring 500 full-time jobs over the next several years, growing our state’s workforce and allowing us to manufacture more goods domestically – enhancing our economic competitiveness on the global stage.”

“We are truly looking forward to our partnership with WuXi STA, as the groundbreaking today marks the kick-off to them making their new home in Middletown, Delaware. WuXi STA will be joining our bustling industrial area, just steps away from Clarios, Datwyler, Amazon and Breakthru Beverage, just some of the companies that have invested in Middletown. When asked by WuXi STA about our business-friendly attitude, these businesses expressed their wholehearted support for how we do business and we couldn’t be more excited about WuXi STA wanting to join them, and the Town of Middletown, in our journey together,” said Middletown Mayor Ken Branner. Branner added he was thankful for the support of Gov. John Carney and the Delaware Prosperity Partnership.

“I would like to thank our federal, state and local partners in Delaware for their continued support in the establishment of this site,” said Dr. Minzhang Chen, co-CEO of WuXi AppTec and CEO of WuXi STA. “WuXi STA continues to increase our capabilities and capacities to better serve our customers through a more robust and reliable supply chain. With our integrated Contract Research, Development, and Manufacturing Organization (CRDMO) platform and proven quality system, we look forward to working with our customers to swiftly deliver their innovative therapies to market in order to save lives and improve healthcare for patients.”

The WuXi STA Middletown facility is expected to begin operations in 2025.

About WuXi STA

WuXi STA (stapharma.com), a subsidiary of WuXi AppTec (wuxiapptec.com), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry with global operations. As a premier Contract Research, Development, and Manufacturing Organization (CRDMO), WuXi STA offers its worldwide partners efficient, flexible and high-quality solutions for integrated chemical, manufacturing and controls (CMC) from preclinical to commercial uses, including the development and manufacturing of small molecule, oligonucleotide, peptide and various complex chemical conjugate. For more information, please visit: http://www.STApharma.com

About WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,850 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.” Please visit: http://www.wuxiapptec.com

Media Contact:

Davy Wu

mediainquiries@wuxiapptec.com

This article was originally posted at https://www.wuxiapptec.com/news/wuxi-news/5174.

Kurt Foreman

PRESIDENT & CEO

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

Versogen Chooses Delaware for Expansion

WILMINGTON, Del. – Versogen, an industry-leading green energy startup, has chosen Delaware as the site for a $4.8 million expansion that includes moving its operations from The Innovation Space in Wilmington, Delaware, to larger, upgraded facilities at FMC Stine Research Center in Newark, Delaware.

Versogen targets deep decarbonization of the sectors of our economy that are not possible by green electricity. The startup is focused on anion-exchange membranes (AEMs) and AEM based electrolyzers to produce low-cost green hydrogen at scale. The company’s systems are engineered to make green hydrogen affordable and sustainable – from the materials used in manufacturing through to the costs of operations.

“Delaware has been a hub for innovation for decades. Versogen is the latest success out of Delaware’s Innovation Space and a great example of the collaborative environment we have for economic development in our state,” said Governor John Carney. “We are excited for Versogen’s expansion, bringing new jobs and important technologies to New Castle County.”

Versogen’s investment includes renovating Stine Building 115 and creating additional lab space at the site, which will be fully operational by 2024. The company’s relocation will accommodate its next level of operations, which includes adding forty-nine new jobs over the next three years to the 16 positions currently staffing the company.

“New Castle County is the ideal place for startup companies like Versogen to create innovative green technologies,” said New Castle County Executive Matt Meyer. “We are proud to welcome Versogen and know that it will find the first-rate talent for employees and further growth.”

Officials from FMC agreed.

“At the FMC Stine Research Center, we work hard to change the world for the better,” said Dr. Kathleen Shelton, FMC executive vice president and chief technology officer. “We are excited to welcome Versogen and applaud them for developing industry-leading green energy technologies. We appreciate Delaware Prosperity Partnership for the continued collaboration and actively building a strong entrepreneurial and innovation ecosystem in the State of Delaware.”

Versogen officials presented today to Delaware’s Council on Development Finance the company’s application for a Delaware Lab Space Grant of $450,380 and a Jobs Performance Grant of $151,343 from the Delaware Strategic Fund to support the company’s investment of more than $4.8 million. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Versogen’s request for up to $601,723 in total grant funding.

“Versogen has been strongly supported by the State of Delaware directly or indirectly from its inception,” said Yushan Yan, Versogen co-founder and CEO. “The grants approved today for Versogen from the Delaware Strategic Fund demonstrate Delaware’s unwavering commitment to building a vibrant entrepreneurial environment for startups and to providing critically needed facilities grants for them to grow.”

Versogen began with research conducted in Yan’s lab in his role as Henry B. du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware. As Yan said, Delaware recognized the startup’s promise right away. So did entities throughout the United States, with numerous supporting the company’s work to bring to market a new class of polymer membranes that will make green hydrogen and fuel cells more economical.

Originally branded as W7 Energy and rebranded as Versogen in 2021, the company has been supported by more than $5 million in grants. These include the prestigious BIRD Project grant in 2020 and selection as one of three startups for the fourth cohort of the Shell GameChanger Accelerator (GCxN) program in 2021.

Earlier this year, Versogen closed a Series A funding round that raised $14.5 million. This investment allows the company to scale development of its low-cost green hydrogen electrolyzer stacks.

###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About Versogen

Versogen is an industry-leading green energy startup founded by Yushan Yan, the Henry B. du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware and a member of the National Academy of Engineering. The company’s focus is decarbonizing heavy, hard-to-abate carbon by producing low-cost green hydrogen with its zero-emission AEM electrolyzer that uses natural materials, water and renewable energy to produce hydrogen at scale. Versogen systems are engineered to make green hydrogen affordable and sustainable – from the materials used in manufacturing right through to the costs of operations.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

LaMotte Chooses Delaware for Expansion

LaMotte Company Chooses Newark, Delaware, for Manufacturing and R&D Expansion

LaMotte Company expands R&D and lab in Delaware

Water-Quality Testing Instrumentation and Reagent Company Investing $3.3M in New Pencader Corporate Center Site, Adding More Than 100 New Jobs in Delaware


(WILMINGTON, Del. ) — LaMotte Company, a leading producer of water-quality testing instrumentation and reagents, headquartered in Chestertown, Maryland, has chosen Newark, Delaware, as the site for its expansion. Sales growth has prompted LaMotte to increase its manufacturing and research and development capacity.

The company plans to invest $3.3 million to build out lab space at its new location in Pencader Corporate Center. The 79,000-square-foot site also will include office and production space.

“We are working hard to make Delaware more competitive so that we can compete and win every day,” said Governor John Carney. “That means making sure we have the best environment so businesses like LaMotte Company can grow and thrive here in Delaware. We are excited for this expansion and the new jobs it will bring. This investment shows that Delaware remains in demand for manufacturing and innovative development.”

LaMotte will hire more than 50 employees immediately with future plans to have more than 100 people working at the site within three years. Positions will include skilled technicians, production line and warehouse workers, administrative positions, and engineers and chemists.

Proximity to the intellectual resources of the University of Delaware was a key reason for LaMotte’s choice of Newark, Delaware, over other Mid-Atlantic locations. The company intends to collaborate with the university’s College of Engineering and Lerner College of Business & Economics to develop an internship and employee pipeline. It also plans to partner with Delaware’s vocational high schools and Delaware Technical Community College to address its needs for technician and manufacturing personnel.

“We are excited to learn of LaMotte Company’s plans to expand to New Castle County,” said County Executive Matt Meyer. “We also thank the leadership and vision of Delaware Prosperity Partnership in helping to bring exciting and innovative employment opportunities to Delawareans.”

Founded in Baltimore, Maryland, LaMotte has manufactured specialized pH indicators and other analytical reagents for water-quality analysis worldwide since 1919. Today, the company produces analytical reagents, electronic instrumentation, and complete portable test kits for chemical analysis for hundreds of applications to serve the pool and spa; drinking water; industrial water; environmental science education; food and beverage; laundry and sanitation; water and wastewater; and aquarium and fish farming industries.

LaMotte officials presented to Delaware’s Council on Development Finance, requesting a performance-based grant of $190,440 and a Delaware Lab Space Grant of almost $1.06 million from the Delaware Strategic Fund. Distribution of grants from the Delaware Strategic Fund is dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved the request.

“We are thrilled to continue our expansion plans culminating in this investment in Delaware,” said LaMotte President and CEO Scott Amsbaugh. “The Newark location is highly valuable for us given the skilled and educated local workforce and its proximity to global shipping hubs. This investment is critical in our capacity expansion to meet our customers’ growing demands for LaMotte’s products.” 

Delaware Prosperity Partnership began working with LaMotte in June 2021 on its site selection process.

###

About Delaware Prosperity Partnership

Delaware Prosperity Partnership leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

About LaMotte Company

Founded in Baltimore, Maryland, LaMotte Company is headquartered on its own 15-acre industrial park near colonial Chestertown on Maryland’s Eastern Shore. The company is a leading manufacturer of analytical reagents, laboratory apparatus, electronic instrumentation and complete portable test kits for chemical analysis in hundreds of applications. Since 1919, LaMotte has been a committed leader in providing quality equipment and guidance for water analysis. LaMotte’s first major catalog, published in 1930, anticipated many of the areas in which accurate chemical control is indispensable today: boiler water, swimming pools, drinking water and more. Today, the company produces a broad line of portable test equipment and continues its focus on specific needs by offering reliable products and exceptional technical support and customer service to guarantee satisfaction.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading